PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
This activity also relates to 8331-Strategic Information.
The Medical Research Council (MRC) has worked in Uganda since 1989 conducting population-based evaluations in conjunction with the MOH and other partners to inform the control of the HIV/AIDS epidemic and its consequences. For example, in collaboration with the Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine MRC is currently conducting large-scale field trails on HIV-prevention strategies and ARV therapy approaches. As part of this, they have over 40 clusters, defined as groups of communities being evaluated. In late FY04 a partnership between MRC, CDC and TASO was established to conduct an evaluation to compare facility- and home-based ART service delivery systems. The study population comprises 1000 current TASO clients served in the Jinja District branch. During that time the study protocol was developed and approved, and systems to begin data collection were designed. In FY05 activities focused on training TASO health care providers in delivering ART services to clients using both the facility-based and home-based service delivery models; the enrollment of clients for the evaluation; initial client registration data collection; an analysis of the existing TASO services and data for the clients enrolled. In FY06, MRC through a sub-partner agreement with TASO provided funding to procure ARTs and other related OI drugs for the 1,000 clients recruited as part of the targeted evaluation.
In FY07 follow-up of clients on ART will continue and clinical, laboratory, social, economic and behavioral data will be recorded. The purpose of the evaluation is to follow the 1000 ART clients enrolled to measure the two service delivery models effectiveness and costs, client behavior and adherence and, family counseling and testing uptake. Other related MRC activities outlined in the strategic information section are to provide support and technical assistance to TASO's HMIS unit and assist TASO with the conduct of population-based client survey on behavior with treatment and adherence to the drug regime. The activity will strengthen TASO's capacity in the collection and interpretation of client and service delivery data to inform clinical services and program management. MRC/UVRI will also conduct the evaluation activities to compare the effectiveness of both strategies. The primary outcome indicator for this evaluation is the number of clients who experience treatment failure as measured by a viral load of >500 copies/microlitre after initial successful viral suppression. Other outcomes include treatment adherence and uptake of VCT services by clients' family members. Evaluation findings will be shared as appropriate to inform the national program and other provider on the most effective approaches for clients to access HIV care and treatment in resource-limited settings.
This activity also complements activity 8332-ARV drugs. As ART is scaled up in Africa, policy makers will need to know how home-based and facility-based delivery systems are associated with treatment outcomes and the cost-effectiveness of each service delivery model. In late FY04 a partnership between MRC, CDC and TASO was established to conduct an evaluation to compare facility and home-based ART service delivery systems. The study participants compromised 1000 current TASO clients at the TASO Jinja District branch. In early FY05, the study protocol was developed and approved, and systems to begin data collection were designed. Other FY05 activities focused on training TASO health care providers in delivering ART services to clients using both the facility-based and home-based service delivery models; the enrollment of clients for the evaluation; initial client registration data collection; and, an analysis of the existing TASO services and data for the clients enrolled. In FY06, MRC worked with TASO and continued data collection and analysis according to the approved protocol. Clients were interviewed and specimens collected at baseline and at 6-month follow-up visits. In FY07, MRC will continue follow-up of clients to record clinical events, collect data on service delivery model and patient costs, client behavior and adherence, family counseling and testing and collect specimens for analysis. Follow-up visits will occur at 6-monthly intervals. This will all be done according to the approved protocol. In addition MRC will provide support and technical assistance to TASO's HMIS unit and assist TASO with the conduct of population-based client survey on behavioral aspects of treatment and adherence to the drug regime. The activity will strengthen TASO's capacity in the collection and interpretation of client and service delivery data to inform clinical services and program management. MRC will also conduct the evaluation analysis activities to compare the cost effectiveness of both strategies. The primary outcome indicator for this evaluation is the number of clients who experience treatment failure as measured by a viral load of >500 copies/microlitre after initial successful viral suppression. Other outcomes include treatment adherence and uptake of VCT services by clients' family members. Evaluation findings will be shared to inform the national program and other providers on the most effective approaches for clients to access HIV care and treatment in resource-limited settings.
